+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

U.S. Opioids Market, by Drugs, by Therapeutic Application, and by Distribution Channel - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

  • PDF Icon

    Report

  • 156 Pages
  • June 2022
  • Region: United States
  • Coherent Market Insights Pvt Ltd.
  • ID: 5626494
Opioids can be defined as a class of drugs, which include the drug heroin, synthetic opioids such as fentanyl, and various pain relievers prescribed legally, such as oxycodone, hydrocodone, and others. This class of drug is primarily taken for pain relief. It has been used for other medical purposes including cough and diarrhea treatment. They bind to opioids receptor and produce a desirable result. In recent years, there has been an increase in the use of prescription opioids for the treatment of chronic, non-cancer pain, such as back pain or osteoarthritis, despite serious risks and the lack of evidence about their long-term effectiveness. Opioids are generally safe when taken for a short time, regular use of the drug can lead to dependence and in extreme cases may even result in death. Opioids are addicting because they not only relieve pain but also generate euphoria. This, combined with the development of tolerance (the need to raise dosages to achieve the same effect), can result in opioid use disorder. As a result, prescribers have changed their methods to minimize the length and potency of opioids in an attempt to prevent addiction.



Market Dynamics


The increasing rate of unemployment is expected to drive the market growth, owing to the increased opioids misuse. For instance, according to an article published by AzoNetwork, an online publisher, in May 2022, two studies led by the National Survey of Drug Use and Health (NSDUH), and the national population-based Midlife in the U.S. (MIDUS) Study found that strong associations between drug misuse generally and opioid misuse specifically among unemployed Americans, who were found to have a 40% higher likelihood to misuse opioids than those working 35-40 hours per week.

Key features of the study:

  • This report provides an in-depth analysis of the U.S. opioids market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, country outlook, and competitive strategies adopted by key players
  • It profiles key players in the U.S. opioids market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Purdue Pharmaceuticals L.P., Titan Pharmaceuticals, Inc., Pfizer Inc., Mallinckrodt, Pfizer Inc., Assertio Holdings, Inc., Par Pharmaceutical, Amneal Pharmaceuticals LLC, Trevena, Inc., Lupin, and Endo Pharmaceuticals, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The U.S. opioids market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts1
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the U.S. opioids market

Detailed Segmentation:

U.S. Opioids Market, By Drugs:

  • Codeine
  • Fentanyl
  • Meperidine
  • Methadone
  • Morphine
  • Hydrocodone

U.S. Opioids Market, By Therapeutic Application:

  • Pain Management
  • Neuropathic Pain
  • Migraine
  • Back Pain
  • Osteoarthritis Pain
  • Cancer Pain
  • Others
  • Cough Treatment
  • Diarrhea Treatment

U.S. Opioids Market, By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Company Profiles:

  • Purdue Pharmaceuticals L.P.
  • Company Highlights
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Titan Pharmaceuticals, Inc.
  • Pfizer Inc.
  • Mallinckrodt
  • Pfizer Inc.
  • Assertio Holdings, Inc.
  • Par Pharmaceutical
  • Amneal Pharmaceuticals LLC
  • Trevena, Inc.
  • Lupin
  • Endo Pharmaceuticals, Inc.
Frequently Asked Questions about the U.S. Opioids Market

What is the estimated value of the U.S. Opioids Market?

The U.S. Opioids Market was estimated to be valued at $16285.2 Million in 2022.

What is the growth rate of the U.S. Opioids Market?

The growth rate of the U.S. Opioids Market is 5.5%, with an estimated value of $24948.4 Million by 2030.

What is the forecasted size of the U.S. Opioids Market?

The U.S. Opioids Market is estimated to be worth $24948.4 Million by 2030.

Who are the key companies in the U.S. Opioids Market?

Key companies in the U.S. Opioids Market include Purdue Pharmaceuticals L.P., Titan Pharmaceuticals, Inc., Pfizer Inc., Mallinckrodt, Pfizer Inc., Assertio Holdings, Inc., Par Pharmaceutical, Amneal Pharmaceuticals LLC and Lupin.

Table of Contents

1. Research Objectives and Assumptions
  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview
  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snapshot, By Drugs
  • Market Snapshot, By Therapeutic Application
  • Market Snapshot, By Distribution Channel
  • Publisher Opportunity Map

3. Market Dynamics, Regulations, and Trends Analysis
  • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Recent Developments
  • Acquisitions and Partnerships Scenario
  • Technology Overview
  • Regulatory Scenario
  • PEST Analysis

4. U.S. Opioids Market- Impact of Coronavirus (Covid-19) Pandemic
  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the market

5. U.S. Opioids Market, By Drugs, 2017 - 2030, (US$ Million)
  • Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
  • Codeine
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Fentanyl
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Meperidine
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Methadone
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Morphine
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Hydrocodone
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. U.S. Opioids Market, By Therapeutic Application, 2017 - 2030, (US$ Million)
  • Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
  • Pain Management
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Neuropathic Pain
  • Migraine
  • Back Pain
  • Osteoarthritis Pain
  • Cancer Pain
  • Others
  • Cough Treatment
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Diarrhea Treatment
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. U.S. Opioids Market, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
  • Hospital Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Online Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Competitive Landscape
  • Purdue Pharmaceuticals L.P.
  • Titan Pharmaceuticals, Inc.
  • Pfizer Inc.
  • Mallinckrodt
  • Pfizer Inc.
  • Assertio Holdings, Inc.
  • Par Pharmaceutical
  • Amneal Pharmaceuticals LLC
  • Trevena, Inc.
  • Lupin
  • Endo Pharmaceuticals, Inc.

9. Section
  • Research Methodology
  • About Us

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Purdue Pharmaceuticals L.P.
  • Titan Pharmaceuticals, Inc.
  • Pfizer Inc.
  • Mallinckrodt
  • Pfizer Inc.
  • Assertio Holdings, Inc.
  • Par Pharmaceutical
  • Amneal Pharmaceuticals LLC
  • Trevena, Inc.
  • Lupin
  • Endo Pharmaceuticals, Inc.